Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Berenberg Initiates Coverage On Relay Therapeutics with Buy Rating, Announces Price Target of $45
Berenberg initiates coverage on Relay Therapeutics (NASDAQ:RLAY) with a Buy rating and announces Price Target of $45.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Anixa Biosciences (NASDAQ:ANIX) stock moved upwards by 9.1% to $3.35 during Tuesday's after-market session. The company's market cap stands at $100.9 million.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
56 Biggest Movers From Yesterday
Gainers
Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers
Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 228.5% to $7.26 during Tuesday's regular session. The company's market cap stands at $95.8 million.
Relay Therapeutics Q3 EPS $(0.66) Misses $(0.64) Estimate
Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.64) by 3.13 percent. This is a 78 percent increase over losses of $(3.00) per share from
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.